News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Conference News EAS 2020 Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank Michael O'Riordan October 07, 2020
News Daily News Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD Michael O'Riordan September 22, 2020
News Daily News LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes Yael L. Maxwell September 14, 2020
News Conference News ESC 2020 EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression Yael L. Maxwell September 02, 2020
News Daily News Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated Yael L. Maxwell August 27, 2020
News Daily News Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin Michael O'Riordan August 25, 2020
News Daily News Could Statins Curb Fatal or Severe COVID-19? Some Clues Michael O'Riordan August 14, 2020
News Daily News CV Prevention Meds Underused in Hispanic, Latinx PAD Patients L.A. McKeown August 12, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests Todd Neale August 03, 2020
News Daily News Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE Michael O'Riordan July 08, 2020
News Daily News Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data Yael L. Maxwell July 07, 2020
News Daily News Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly Michael O'Riordan July 06, 2020
News Daily News Rural-Urban Gap Widens for Cardiometabolic Health Disparities Michael O'Riordan June 22, 2020
News Daily News Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades Yael L. Maxwell May 28, 2020
News Daily News Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans Michael O'Riordan May 15, 2020
News Daily News FOURIER Surveys Reassure About Cognitive Safety of Evolocumab Todd Neale May 06, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020